Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Optimum Therapeutics LLC
Profile last edited on: 4/11/2016      CAGE: 4FHQ8      UEI: CAAGN783MMF1

Business Identifier: Biotechnology research and development laboratory
Year Founded
2003
First Award
2003
Latest Award
2012
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

1381 Kinnear Road Suite 111
Columbus, OH 43212
   (614) 688-5885
   optimum_t@sbcglobal.net
   www.optimumtx.com
Location: Single
Congr. District: 03
County: Franklin

Public Profile

Optimum is focused to linking academic discoveries with commercial applications to provide the maximum benefits to cancer research and patients. The firm's scientists have pursued and developed research into treatments for several different types of cancer.

Extent of SBIR involvement

User Avatar
Phase I Awards
7
Phase II Awards
4
Conversion Rate
57.14%
Phase I Dollars
$1,573,101
Phase II Dollars
$3,613,099
Total Awarded
$5,186,200

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2012 2 NIH $1,552,826
Project Title: Apoptosis Inducing to Enhance Tumor Targeting
2012 2 NIH $303,226
Project Title: Intra-Bladder Mmc &Suramin for Nonmuscle-Invading &Locally Advanced Bladder Ca
2012 1 NIH $344,460
Project Title: Combination Chemo-Sirna Gene Therapy of Nonmuscle-Invading Bladder Cancer
2009 2 NIH $248,174
Project Title: Intraperitoneal Tumor-Targeting Chemo-Gene Therapy
2009 2 NIH $2,376,017
Project Title: Bladder Tumor Targeting by Intravesical Paclitaxel

Key People / Management

  Jessie Au -- fFounder, Chief Scientific Officer and Acting CEO

  Ze Lu -- Senior Research Scientist

  Jie Wang

  Teng-Kuang Yeh

Company News

There are no news available.